NKTX Earnings Date: Nov 10, 2026 (Estimated) — Nkarta, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is NKTX's next earnings date?
Nkarta, Inc. (NKTX) is expected to report earnings on Tuesday, November 10, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.40.
How did NKTX do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Nkarta, Inc. posted EPS of -$0.54 versus the -$0.36 estimate, a miss of 46.0%. Revenue was $0. The stock's 1-day post-earnings move was -5.3%.
How much does NKTX stock move after earnings?
NKTX beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 9.7% (up or down) in the day after earnings.
About Nkarta, Inc.
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.36 | -0.54 | -45.95% | $0 | ❌ Miss | -5.28% | -1.22% | +18.29% |
| 2026-05-12 | Q1 2026 | -0.37 | -0.37 | +0.00% | $0 | ➖ Inline | -6.71% | -18.29% | -15.85% |
| 2026-03-25 | Q4 2025 | -0.30 | -0.37 | -23.33% | $0 | ❌ Miss | +0.47% | +2.82% | +37.09% |
| 2025-11-10 | Q3 2025 | -0.31 | -0.29 | +6.45% | $0 | ✅ Beat | +2.55% | -7.65% | -4.08% |
| 2025-08-12 | Q2 2025 | -0.36 | -0.31 | +13.89% | $0 | ✅ Beat | +12.76% | +17.35% | +5.61% |
| 2025-03-26 | Q4 2024 | -0.40 | -0.35 | +12.50% | $0 | ✅ Beat | +43.80% | +39.42% | +54.01% |
| 2024-11-07 | Q3 2024 | -0.36 | -0.39 | -8.33% | $0 | ❌ Miss | -2.45% | -17.43% | -24.46% |
| 2024-08-13 | Q2 2024 | -0.47 | -0.34 | +27.66% | $0 | ✅ Beat | +3.22% | +2.82% | +12.47% |
Showing last 8 quarters.